Booming rare disease player Shire adding a trendy new R&D hub in Kendall Square for 1,000-plus
Shire CEO Flemming Ornskov has already made it clear that he intends to make the company a leading force in rare disease drug development and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
